![Performance evaluation of immunoassay for infectious diseases on the Alinity i system - Nam - 2021 - Journal of Clinical Laboratory Analysis - Wiley Online Library Performance evaluation of immunoassay for infectious diseases on the Alinity i system - Nam - 2021 - Journal of Clinical Laboratory Analysis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/15ff41fe-ef67-43fd-9b30-9757c42b17ad/jcla23671-toc-0001-m.jpg)
Performance evaluation of immunoassay for infectious diseases on the Alinity i system - Nam - 2021 - Journal of Clinical Laboratory Analysis - Wiley Online Library
![Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein | Nature Communications Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms13627/MediaObjects/41467_2016_Article_BFncomms13627_Fig1_HTML.jpg)
Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein | Nature Communications
![JCM | Free Full-Text | Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review | HTML JCM | Free Full-Text | Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review | HTML](https://www.mdpi.com/jcm/jcm-11-05006/article_deploy/html/images/jcm-11-05006-g001.png)
JCM | Free Full-Text | Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review | HTML
![Frontiers | Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients? Frontiers | Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?](https://www.frontiersin.org/files/Articles/657144/fimmu-12-657144-HTML/image_m/fimmu-12-657144-g001.jpg)
Frontiers | Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?
![JCM | Free Full-Text | Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review | HTML JCM | Free Full-Text | Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review | HTML](https://www.mdpi.com/jcm/jcm-11-05006/article_deploy/html/images/jcm-11-05006-g002.png)
JCM | Free Full-Text | Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review | HTML
![Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?: Molecular Therapy - Oncolytics Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/2b9314b5-109e-437f-b80f-d1f4d5a0e2db/gr1_lrg.jpg)
Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?: Molecular Therapy - Oncolytics
![Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection | BMC Pregnancy and Childbirth | Full Text Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection | BMC Pregnancy and Childbirth | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12884-019-2360-1/MediaObjects/12884_2019_2360_Fig1_HTML.png)
Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection | BMC Pregnancy and Childbirth | Full Text
Tritest - Virusul herpetic Anticorpii anti-HSV (herpes simplex virus) se testează împreună cu alţi anticorpi (IgG şi IgM) care formează aşa-zisul complex TORCH. TORCH este un acronim pentru Toxoplasma, Rubella (rubeolă), CMV (
![Frontiers | Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation Frontiers | Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation](https://www.frontiersin.org/files/Articles/730765/fimmu-12-730765-HTML-r1/image_m/fimmu-12-730765-g001.jpg)
Frontiers | Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation
![PDF) Human Cytomegalovirus IgG and IgM Seropositivity among Pregnant Women in Sulaimani City and Their Relations to the Abortion Rates PDF) Human Cytomegalovirus IgG and IgM Seropositivity among Pregnant Women in Sulaimani City and Their Relations to the Abortion Rates](https://www.researchgate.net/profile/Salih-Hama/publication/290447101/figure/tbl1/AS:669415192416272@1536612427669/Tested-women-and-CMV-results-regarding-both-IgG-and-IgM_Q320.jpg)